A new consultation proposes ending criminal penalties for small amounts of cannabis, allowing limited home cultivation and clearing eligible convictions. But Cayman must still decide how a lawful market would work, where its cannabis will come from and who will be allowed to participate.
The Cayman Islands has opened public consultation on proposals that could decriminalise possession and private consumption of small amounts of cannabis, permit limited home cultivation and expunge eligible historic convictions.
The Law Reform Commission’s discussion paper, published on July 1, follows the 2025 referendum in which Caymanians voted in favour of decriminalising the possession and consumption of small amounts of cannabis. Public comments are being accepted until September 1, 2026.
The proposals represent meaningful progress. They also expose a contradiction Caribbean governments increasingly have to confront: allowing adults to possess cannabis while leaving almost every practical means of obtaining it outside the law.
The commission acknowledges that decriminalisation alone would not eliminate the illegal market. Its preliminary position, however, would keep commercial cultivation, importation, distribution and sale illegal outside Cayman’s existing medical framework.
Cannabis could therefore become lawful to possess without becoming lawfully accessible.
Possession, cultivation and expungement
The paper proposes allowing adults to possess up to 30 grams of dried cannabis.
It also considers home cultivation, potentially limited to four plants per household, together with a higher allowance for freshly harvested cannabis. Public consumption would remain prohibited.
The commission is also considering the expungement of convictions for conduct that would no longer be illegal.
That matters. Cannabis reform is incomplete when people continue carrying criminal records for behaviour the government has decided should no longer be criminal.
Home cultivation could provide some adults with a lawful supply, but it will not resolve the access question for everyone.
Many people do not have suitable space, cultivation experience, secure premises or the physical ability to grow cannabis. Others simply do not want to.
Decriminalisation may remove the criminal penalty from possession, but it does not explain how most consumers are expected to obtain the cannabis they are permitted to possess.
The Netherlands already tested that contradiction
Cayman would not be the first jurisdiction to separate tolerated possession and retail access from lawful production.
For decades, the Netherlands operated Europe’s most visible cannabis market through its coffeeshop system. Small retail transactions were tolerated under strict conditions, but the commercial cultivation and wholesale supply serving those coffeeshops remained illegal.
This became known as the Dutch “backdoor problem.”
Cannabis could leave through the front door in a tolerated sale, but generally had to enter through an illegal supply chain. Regulators could oversee the consumer-facing transaction without legally controlling how the product was cultivated, transported or supplied.
That allowed criminal growers and wholesalers to remain embedded in the market while limiting oversight of product origin, production conditions and quality.
The Dutch government is now attempting to repair that gap through its Controlled Cannabis Supply Chain Experiment. Coffeeshops in participating municipalities are being supplied by designated growers producing regulated, quality-controlled cannabis, while authorities study the effects on crime, safety and public health.
Cayman is not proposing a Dutch-style coffeeshop market. But the underlying lesson remains relevant:
When governments permit possession while refusing to regulate supply, the supply does not disappear. It remains in the shadows.
The product rules must reflect an actual medical market
The commission’s preliminary approach would largely limit decriminalisation to dried cannabis, excluding oils, tinctures, vapes, edibles and other preparations.
That is difficult to reconcile with a functioning medical framework.
Many patients do not want to smoke. Some have respiratory concerns, arthritis, tremors, mobility limitations or little experience using cannabis. Oils, tinctures, capsules, vaporised products and carefully dosed oral preparations may be more practical for those patients when professionally manufactured, tested and clearly labelled.
The regional direction is also evolving. Barbados’ licensed medical system has offered oils, tinctures and pharmaceutical preparations, with its regulator stating that medicinal cannabis flower products were also being introduced.
The issue is not whether Cayman should favour flower or extracts.
It is whether the country intends to create a coherent legal and medical framework or merely decriminalise one form of cannabis while postponing most questions involving patient access, product standards and lawful supply.
Different formats carry different risks. Vapes require stringent manufacturing and contaminant testing. Edibles require controlled doses, clear labelling and packaging that reduces accidental consumption. Flower also requires testing for pesticides, mould, heavy metals and potency.
Those are reasons to regulate products intelligently—not to assume that the raw plant is inherently more appropriate for medicine.
A credible framework should regulate cannabis according to dosage, manufacturing standards, testing, labelling and patient need.
Jamaica is already part of Cayman’s cannabis supply chain
Cayman is not considering cannabis reform in isolation.
Jamaican companies have already exported regulated medical cannabis products to Cayman. Kaya Extracts previously shipped cannabis oil for medicinal use, and JACANA completed its first regulated medical cannabis export to the Cayman Islands in January 2026.
That existing relationship gives Cayman an advantage the Netherlands did not have when its coffeeshop system developed.
A nearby regulated industry already has cultivation experience, manufacturing capacity and an established export pathway into Cayman.
Smaller Caribbean jurisdictions do not necessarily need to reproduce every part of the cannabis supply chain independently. Regional trade could allow countries to share testing capacity, genetics, manufacturing, training and regulatory knowledge while keeping more of the industry’s value within the Caribbean.
Jamaican cannabis should therefore remain part of Cayman’s future framework.
But regional integration must not become an excuse to exclude Caymanians from their own emerging market.
Any future legal-supply system should also create defined opportunities for Caymanian cultivators, entrepreneurs, pharmacists, manufacturers and wellness providers. Cayman could combine regulated regional imports with limited domestic cultivation, local dispensing and partnerships between Caymanian and Jamaican businesses.
The goal should be regional cooperation without replacing local participation.
Cayman must decide how it intends to legalise
The commission is right to consider youth access, impaired driving, public consumption, product safety and the possible health effects of reform.
But caution should not produce a permanent contradiction.
Cayman can learn from Jamaica, where decriminalisation, licensed cultivation and regulated medical exports now coexist.
It can learn from Barbados, where the medical framework is expanding the products available to patients.
And it can learn from the Netherlands, where tolerated consumer access without legal cultivation created a supply problem authorities are still trying to correct decades later.
Cayman does not need to launch a highly commercial adult-use market overnight.
It does, however, need to acknowledge that possession, products and supply are connected.
Decriminalisation would reduce unnecessary criminalisation. Expungement would correct past harm. Home cultivation could provide some adults with greater independence. Regulated regional imports could support patient access and Caribbean trade.
But those measures must eventually become part of a coherent legalization pathway.
The central questions are no longer simply whether Cayman should decriminalise cannabis.
They are:
Where will lawful cannabis come from?
How will it be regulated?
And equally important:
Who will be allowed to participate in supplying it?
Have your say
The Cayman Islands Law Reform Commission is accepting public comments on the cannabis reform proposals until September 1, 2026.
Comments may be submitted through the government’s public consultation portal or emailed directly to cilawreform@gov.ky. Written submissions may also be delivered or mailed to the Law Reform Commission in George Town.
Are you 18 or older?The law requires you to be 18 years of age or older to enter this website. Please verify your age to view the content, or click "Exit" to leave.
